1. Home
  2. STEP vs STVN Comparison

STEP vs STVN Comparison

Compare STEP & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo StepStone Group Inc.

STEP

StepStone Group Inc.

HOLD

Current Price

$43.19

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$19.37

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEP
STVN
Founded
2007
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Finance/Investors Services
Containers/Packaging
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
STEP
STVN
Price
$43.19
$19.37
Analyst Decision
Buy
Buy
Analyst Count
8
3
Target Price
$71.00
$25.67
AVG Volume (30 Days)
1.6M
304.7K
Earning Date
05-21-2026
05-07-2026
Dividend Yield
2.98%
0.39%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,993,603,000.00
N/A
Revenue This Year
N/A
$9.67
Revenue Next Year
$26.41
$9.99
P/E Ratio
N/A
$27.15
Revenue Growth
69.69
N/A
52 Week Low
$38.85
$12.89
52 Week High
$77.80
$28.00

Technical Indicators

Market Signals
Indicator
STEP
STVN
Relative Strength Index (RSI) 47.20 54.53
Support Level $41.11 $13.58
Resistance Level $49.24 $19.41
Average True Range (ATR) 2.15 0.81
MACD 0.46 0.06
Stochastic Oscillator 56.55 65.46

Price Performance

Historical Comparison
STEP
STVN

About STEP StepStone Group Inc.

StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: